Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual vs Triple Lipid-Lowering Therapies in T2DM Patients With Elevated LDL-C
NCT07255820Phase 4Completed
- Sponsor
- Bahria University
- Start
- Jan 2026
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bempedoic acid in hypercholesterolemia, sponsored by Bahria University. Started Jan 2026; status: completed.
02
Drugs
bempedoic acid
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT07255820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07255820.